Burden of Invasive Group B Streptococcal Disease in Infants and Resistance Surveillance in China
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02812576
Recruitment Status : Unknown
Verified June 2016 by Haiying Liu, Guangzhou Women and Children's Medical Center. Recruitment status was: Recruiting
First Posted : June 24, 2016
Last Update Posted : June 24, 2016
Health Science Center of Xi'an Jiaotong University
Guangzhou Women and Children's Medical Center
Information provided by (Responsible Party):
Haiying Liu, Guangzhou Women and Children's Medical Center
Data on neonatal GBS disease are very limited in China. Acceptance and implementation of prevention measures such as antibiotics prevention or vaccination against GBS disease would require robust data. This study as the first national, multicenter study to investigate the epidemiology of GBS disease in China, and the resistance surveillance of GBS isolates, to appraise the necessity of appropriate interventions.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
up to 90 Days (Child)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
infants <3 months old born in or treated in a study hospital
Positive culture for GBS from normally sterile sites such as blood or cerebrospinal fluid.